Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan
BENGALURU,India,Aug. 29,2024-- Biocon Biologics Ltd (BBL),a fully integrated global biosimilars company and a subsidiary of Biocon Ltd(BSE code: 532523,NSE: BIOCON),announced today that the Company h